Vanberra Signal

HeartSciences

Curated by Signal

Provider of a screening device for the early detection of cardiac dysfunction

Overview

Provider of a screening device for the early detection of cardiac dysfunction. The company has Continuous Wavelet Transform signal processing technology for developing MyoVista cardiac testing device to detect abnormalities of heart function. It provides doctors with a visual description of a cardiac cycle’s energy distribution.

Key facts

Founded
2007

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • Hand-held ultrasound system for body composition assessment

    Life Sciences TechnologyLivermore, United States
  • Algorithms and image-based biomarkers for cancer detection

    Life Sciences TechnologyRockville, United States
  • Non-invasive wearable device using electromagnetic impedance technologies

    Life Sciences TechnologySchenectady, United States

About HeartSciences

What does HeartSciences do?

Provider of a screening device for the early detection of cardiac dysfunction.

Where is HeartSciences headquartered?

HeartSciences is headquartered in Austin, United States.

When was HeartSciences founded?

HeartSciences was founded in 2007.

Which sector is HeartSciences in?

HeartSciences operates in Life Sciences Technology.

Who are HeartSciences's competitors?

Companies similar to HeartSciences include IntelaMetrix, OncoScore, and BioSensors.